Hamza Hashmi

This account is verified. Learn more

@hhashmi87

Myeloma & Cellular Therapy physician at @MSKCancerCenter #MMSM #ASTCT #CART Opinions are my own

New York, USA Joined May 2018

268 Following 1.1K Followers 855 Posts

Latest posts 5

Hamza Hashmi @hhashmi87 6d

Excited to be part of #LouisvilleHematologyHighlights 2026! 🩸

I'll be debating Hans Lee from @SarahCannonDocs on: ➡️Smoldering myeloma: Treat or not to Treat
➡️ASCT in Elderly and High Risk
➡️CAR T vs Bispecific at first Relapse
🥊Bring your questions and your opinions. Which side are you on? 👇
📍 Louisville, KY | 🗓️ 11.7.2026
@UofLBrownCancer #MMsm #hemonc

Mohamed Hegazi Verified account @hemoncer Oct 8

It's that time of year again! 🩸

I'm delighted to invite you to the 4th Annual Louisville Hematology Highlights, a free, in-person CME event bringing together leading experts for a day of cutting-edge updates, lively debates, and multidisciplinary discussions on the latest in hematology.

📅 Saturday, November 7, 2026
📍 Louisville, KY

This year, we're also hosting a parallel nursing symposium, so please bring your whole team. Great patient care is a team effort, and this event is designed with that in mind.

Whether you're a physician, APP, nurse, pharmacist, or trainee, there's something here for you. I hope to see you there!

🔗 [Registration link]

cmetracker.net/ULOU/Publisher…

@awandoc @DrHKantarjian @hhashmi87 @Ramikomrokji @JohnPLeonardMD @lymphomaphilia @NicholasShortMD @MediHumdani
#Hematology #CME #Oncology #CellTherapy #BoneMarrowTransplant #NursingEducation #Louisville #MedicalEducation

View quoted post on X

Hamza Hashmi @hhashmi87 Nov 2

Hot off the Press: Fortunate to be a part of this effort in collaboration with Geriatric Service at @MSKCancerCenter now published in @BloodCancerJnl🎆🙌🎉

Beyond binary: graded frailty assessment and outcomes after CAR-T cell therapy in relapsed/refractory multiple myeloma

rdcu.be/Cg9dNyZSkSRa

#MMSM #MedTwitter #MedEd #OncTwitter #CARTcell #OpenAccess @BloodCancerJnl

Hamza Hashmi @hhashmi87 Oct 21

Thank you @ASNKidney and @SheronLatcha for this great opportunity to share all the marvelous developments in Myeloma with friends and colleagues in Nephrology in Denver!
#CureMyeloma
#MRD
#Transplant
#CastNephropathy
#MGRS
#KidneyWeek

American Society of Onconephrology @onconephsociety Oct 21

📍 Happening now at @ASNKidney KidneyWeek in Denver!

Join us for the ASN OncoNephrology Program for a day of cutting-edge science, emerging cancer therapies, and practical insights.
Are your ready? 🫘

@onconeph @rc_oncneph @SheronLatcha @ShrutiGkidney @PaulHannaMD @hhashmi87

View quoted post on X

Hamza Hashmi @hhashmi87 Oct 19

Thank you @MyelomaTeacher for highlighting our #IMS26 abstract. PET-CT identifies high risk anatomic sites (EM/PM) and early metabolic responders post CAR-T, strengthening the case for integrating functional imaging more systematically into post-CAR-T monitoring and risk-adapted management in myeloma.
#MMSM @Myeloma_Society #CART @MSK_RadOnc @brandon_imber

@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher Oct 18

PET-CT After Cilta-Cel CAR-T: Can Scans Predict #Myeloma Relapse? | #IMS2026 #mmsm @hhashmi87
youtu.be/ZD_4rFahDAM
View quoted post on X

Hamza Hashmi @hhashmi87 Oct 14

In this episode, @AjaiChari and I discuss patient selection, functional vs genomic high-risk disease, appropriate bridging therapy, and why early referral for CAR T are important for durable disease control
#MultipleMyeloma #MMSM #CART @Myeloma_Society @OncUpdates

OncUpdates Verified account @OncUpdates Oct 12

⭐️Earlier CAR T-Cell Therapy in #MultipleMyeloma

🎙️ @hhashmi87 @AjaiChari 🗣️ #IMS26 insights

✅ Consider CAR T at 1st relapse for high-risk disease
✅ Refer early
#mmsm #HemOnc #OncTwitter #CART #MedEd @IMFmyeloma @Myeloma_Society

🎥 Full discussion👇
oncupdates.com/video-podcasts…
View quoted post on X